Mr. Joern Andreas reports

CEAPRO SIGNS EXCLUSIVE LONG-TERM SUPPLY AND DISTRIBUTION AGREEMENT WITH LEADING GLOBAL PROVIDER OF ACTIVE INGREDIENTS, SYMRISE

Ceapro Inc. has signed a long-term agreement with German-based multinational Symrise AG for the distribution and commercialization of Ceapro's high-value active ingredients to major key international players in the cosmetic market.

Under the agreement, Symrise is guaranteed to purchase minimum annual volumes of Ceapro's high-value active ingredients. Financial terms of the agreement were not disclosed.

"Symrise has been and will continue to be a valued, committed partner and we are very pleased to have renewed this agreement with them. This agreement not only provides security for our ongoing cosmeceuticals base business but also is expected to enable us to accelerate the growth of that base business through the potential to expand the list of exclusive customers to Symrise. We are delighted for the vote of confidence towards our company and especially for the recognition of the quality and uniqueness of Ceapro's products," said Gilles Gagnon, president and chief executive officer of Ceapro. "We are confident that our partnership with Symrise, one of the most respected player in our industry, will continue to equally aid in the achievement of our common goals," he added.

"Ceapro and Symrise have a long-standing relationship in product development that has benefited both companies over the years," said Joern Andreas, president, cosmetic ingredients division, Symrise. "We see great value in this partnership and are very pleased to have secured this agreement, which will continue to pave the way for future developments that I believe will benefit both companies in creating value."

About Ceapro Inc.

Ceapro is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical and therapeutics products for humans and animals. The company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug delivery solutions.